Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Healthcare Biotechnology
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces First Quarter Fiscal 2021 Results

Canada NewsWire March 1, 2021

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Canada NewsWire February 26, 2021

Covalon Announces Fiscal 2020 Year-End Results

PR Newswire January 28, 2021

Covalon Announces Appointment of Amir Boloor as Board Chair and Voting Results from Fiscal 2019 Annual and Special Meeting of Shareholders

Canada NewsWire November 13, 2020

Covalon Initiates Strategic Review to Enhance Shareholder Value

Canada NewsWire October 21, 2020

Covalon Announces Third Quarter Fiscal 2020 Results

Canada NewsWire August 24, 2020

Covalon Announces Conference Call to Discuss Third Quarter Financial Results

Canada NewsWire August 21, 2020

Covalon Announces Second Quarter Fiscal 2020 Results

Business Wire July 14, 2020

Covalon Provides Business Update

Canada NewsWire June 30, 2020

Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe

Canada NewsWire June 3, 2020

Covalon Delays Filing of Interim Financial Statements Due to Delays Related to COVID-19 and Provides Business Update

Canada NewsWire May 29, 2020

Amir Boloor Joins Covalon's Board of Directors

Business Wire April 27, 2020

Martin Goldfarb, O.C., Joins Covalon's Board of Directors

Business Wire April 23, 2020

Covalon Postpones Annual Meeting of Shareholders Due to COVID-19

Business Wire April 14, 2020

Covalon Announces Conference Call to Discuss New CovaGuard Antimicrobial Technology

Business Wire April 3, 2020

IIROC Trading Resumption - COV

Canada NewsWire April 1, 2020

Covalon Clarifies Previous Press Release

Business Wire March 31, 2020

IIROC Trading Halt - COV

Canada NewsWire March 31, 2020

Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

Business Wire March 31, 2020

Covalon Announces First Quarter Fiscal 2020 Results

Business Wire March 2, 2020